Moneycontrol PRO
you are here: HomeNewsIndia

Don't see an early end to the 'new normal', yet the show must go on: Apollo Tyres CMD Onkar S Kanwar

In view of a bleak global, Indian and European outlook, the tyre major has adopted a "cautious approach" with focus on employee safety, conserving cash, re-engineering production and cutting down all avoidable costs while continuing to spend on R&D, e-training and brand building, among others.

July 29, 2020 / 03:41 PM IST
Onkar Kanwar, CMD, Apollo Tyres

Onkar Kanwar, CMD, Apollo Tyres

  • bselive
  • nselive
Todays L/H

Stating that the uncertainty due to the coronavirus pandemic will continue, Apollo Tyres Chairman and Managing Director Onkar S Kanwar has said he doesn't see an early end to the 'new normal'.

In view of a bleak global, Indian and European outlook, the tyre major has adopted a "cautious approach" with focus on employee safety, conserving cash, re-engineering production and cutting down all avoidable costs while continuing to spend on R&D, e-training and brand building, among others.

"FY20 was a tough year by all measures. While the auto industry had been on a slow growth path even in FY19, the last year proved to be a complete dampener for the industry due to poor consumer sentiment, increased cost of ownership on account of higher insurance cost, and higher financing cost owing to the liquidity crisis in the non-banking financial company (NBFC) sector," Kanwar said in his address to shareholders in the company's annual report for 2019-20.

He, however, said the company is still bullish about the economy bouncing back and "did see signs of a recovery in the third quarter, but the fourth quarter witnessed headwinds in the form of the COVID-19 outbreak and the subsequent nation-wide lockdown".

"India saw its economic growth hitting an 11-year low of 4.2 percent for FY20, even as the auto industry sales fell 18 percent, adversely impacting the entire tyre industry, which, in turn, declined by 8 percent, in terms of total tyres manufactured," Kanwar said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Looking ahead, he said "it is reasonable to assume that the uncertainty will continue. I personally do not see an early end of this 'new normal'. Yet, the show must go on and we are already adapting and finding opportunities for growth."

Kanwar further said the company's immediate priority is the safety and well-being of its employees, even as it continues to make the "'new normal' our normal".

Despite the crisis, he said, "We have been able to organise the virtual inauguration of our seventh manufacturing plant in Andhra Pradesh, India in June 2020.

"This was closely followed by the opening of our facility to manufacture high-end bias and steel radial tyres for the two-wheeler segment in Limda, Gujarat, India in July 2020."

On the overall outlook, Apollo Tyres said against the bleak global, Indian and European outlook, it has adopted a cautious approach.

"The focus is on employee safety and conserving cash. The company is re-engineering production and cutting down all avoidable costs and focusing on the good costs like R&D, e-training and brand building, among others," it said.

COVID-19 has grave consequences for the automobile industry and all related sectors, with most automobile manufacturers having announced temporary closure of plants due to collapsing demand, supply shortages and government measures.

"OEMs (original equipment manufacturers) in India are forecasting a de-growth of 30-40 percent in FY21 demand given the BS-VI implementation and price increase, COVID-19 impact, poor consumer sentiment and liquidity crunch, which in turn will seriously impact the tyre industry," the company said.

Apollo Tyres Vice-Chairman and Managing Director Neeraj Kanwar said, "Looking ahead at FY21, we are aware that the COVID-19 pandemic and the lockdown will have serious implications on the business. It has been a difficult few months for us – having to temporarily close our plants and making tough decisions on cost-cutting across the board."

However, he said the company is looking at challenges as opportunities and has already launched multiple initiatives under the DRIVE leadership theme to re-engineer Apollo Tyres.

"We are learning from the pandemic experience and will make this our new normal as we energise the entire company to achieve higher productivity," he said.

Follow our full coverage of the coronavirus pandemic here.

first published: Jul 29, 2020 03:30 pm